Menatetrenone
- Generic Name
- Menatetrenone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C31H40O2
- CAS Number
- 863-61-6
- Unique Ingredient Identifier
- 27Y876D139
- Background
Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.
- Indication
适用于骨质疏松症的骨量和疼痛的改善。
- Associated Conditions
- Osteoporosis
- Associated Therapies
- -
The Effect of Vitamin K Supplementation on Glucose Metabolism
- First Posted Date
- 2009-08-18
- Last Posted Date
- 2011-08-10
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT00960973
- Locations
- 🇰🇷
Seoul National University Medical School, Seoul, Korea, Republic of
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2008-12-09
- Lead Sponsor
- Eisai Limited
- Target Recruit Count
- 540
- Registration Number
- NCT00165633
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath